SMAD4 and colorectal carcinoma: Inactivating mutations in SMAD2, SMAD3, and SMAD4 genes have also been observed in sporadic CRC [79,124,125] and have been suggested to reduce their protein stability or to interfere with the formation of SMAD complexes involved in downstream transcriptional responses [124].